Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2017-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1700634114PMID 28396421PMCID PMC5410843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure of the transmembrane domain of HIV‐1 envelope glycoprotein

  2017cited by this paper
• Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.

  2016cited by this paper
• Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability

  2016cited by this paper
• Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer

  2016cited by this paper
• Structural basis for membrane anchoring of HIV-1 envelope spike

  2016influential reference
• A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene

  2015cited by this paper
• Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env.

  2015cited by this paper
• Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein

  2015influential reference
• Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

  2014cited by this paper
• Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions

  2014cited by this paper
• Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure

  2014cited by this paper
• Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies

  2014cited by this paper
• Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

  2013cited by this paper
• Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41

  2013cited by this paper
• A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

  2013cited by this paper
• Phenotypic properties of transmitted founder HIV-1

  2013cited by this paper
• Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans

  2013cited by this paper
• HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120

  2012cited by this paper
• Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation

  2012cited by this paper
• A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies

  2012cited by this paper
• Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5

  2012cited by this paper
• Scikit-learn: Machine Learning in Python

  2011cited by this paper
• A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

  2011cited by this paper
• Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody.

  2010cited by this paper
• Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies

  2010cited by this paper
• Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies

  2009cited by this paper
• Identification of Subtype B, Multiple Circulating Recombinant Forms and Unique Recombinants of HIV Type 1 in an MSM Cohort in China

  2008cited by this paper
• Viral membrane fusion

  2008cited by this paper
• A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

  2008cited by this paper
• Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens.

  2007cited by this paper
• Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1

  2006cited by this paper
• Antigenic conservation and immunogenicity of the HIV coreceptor binding site

  2005cited by this paper
• Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1.

  2004cited by this paper
• Rapid evolution of the neutralizing antibody response to HIV type 1 infection

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Random Forests

  2001cited by this paper
• The carboxy-terminal domain initiates trimerization of bacteriophage T4 fibritin.

  1999cited by this paper
• Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

  1998cited by this paper
• Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Core structure of gp41 from the HIV envelope glycoprotein.

  1997cited by this paper
• Atomic structure of the ectodomain from HIV-1 gp41

  1997cited by this paper
• Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

  1990cited by this paper

• A multi-scale nanoparticle delivery system enhances neutralizing antibody responses in subunit vaccines

  2025cites this paper
• Comprehensive maps of escape mutations from antibodies 10-1074 and 3BNC117 for Envs from two divergent HIV strains

  2025cites this paper
• Comprehensive maps of escape mutations from antibodies 10-1074 and 3BNC117 for Envs from two divergent HIV strains

  2025cites this paper
• Incompletely closed HIV-1CH040 envelope glycoproteins resist broadly neutralizing antibodies while mediating efficient HIV-1 entry

  2025cites this paper
• Current methods for detecting and assessing HIV-1 antibody resistance

  2025cites this paper
• Comprehensive Insights into the Molecular Basis of HIV Glycoproteins

  2024cites this paper
• Sendai virus particles carrying target virus glycoproteins for antibody induction.

  2022cites this paper
• Broadly neutralizing monoclonal antibodies for HIV prevention

  2021cites this paper
• A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex

  2020cites this paper
• Sensitivity to Monoclonal Antibody 447-52D and an Open Env Trimer Conformation Correlate Poorly with Inhibition of HIV-1 Infectivity by SERINC5

  2020cites this paper
• HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 Viruses

  2020influential citation
• Molecular Mechanism of HIV-1 Entry.

  2019cites this paper
• Cryo-EM structure of full-length HIV-1 Env bound with the Fab of antibody PG16

  2019influential citation
• Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.

  2018cites this paper
• Structural basis of coreceptor recognition by HIV-1 envelope spike

  2018cites this paper
• Structural basis of coreceptor recognition by HIV-1 envelope spike

  2018cites this paper
• HIV-1 Env gp41 Transmembrane Domain Dynamics are Modulated by Lipid, Water, and Ion Interactions

  2018cites this paper
• Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11

  2018cites this paper
• Role of envelope compactness and glycosylation in HIV-1 resistance to neutralising antibody responses

  2017influential citation
• Neutralization tiers of HIV-1

  2017cites this paper
• Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time

  2017cites this paper